Followers | 6 |
Posts | 2155 |
Boards Moderated | 0 |
Alias Born | 11/26/2014 |
Friday, October 20, 2017 3:04:00 PM
1. Costs plus. IPCI will be paid to manufacture and supply product to MNK.
2. Profit sharing. IPCI will share in the profits with MNK.
3. Cost recovery. IPCI will be paid cost recovery $. It is not 100% clear how this will be paid but some people feel it is a higher % of profits until the predetermined amount is exhausted.
That being said here is what I am forecasting for 2017Q4:
1. All(includes all 3 listed above) Seroquel XR Revenues- $1.5-2M.
2. Focalin XR revenue- $0.5-1M.
3. MNK amortization- $75K
Grand total- $2.075-3.075M
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM